tiprankstipranks
Cell Source Inc (CLCS)
OTHER OTC:CLCS
US Market
CLCS
Cell Source
RESEARCH TOOLSreports

Cell Source (CLCS) Financial Statements

12 Followers

Cell Source Financial Overview

Cell Source's market cap is currently $39.87M. The company's EPS TTM is $-0.1422; its P/E ratio is -5.79; Cell Source is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -2.73M$ -3.85M$ -4.33M$ -4.17M$ -4.02M
EBITDA$ -2.73M$ -3.60M$ -4.22M$ 0.00$ -93.00K
Net Income$ -4.64M$ -4.77M$ -5.32M$ -5.17M$ -5.47M
Balance Sheet
Cash & Short-Term Investments$ 461.86K$ 74.63K$ 22.20K$ 222.66K$ 93.09K
Total Assets$ 464.11K$ 286.50K$ 195.17K$ 409.85K$ 313.77K
Total Debt$ 12.98M$ 10.07M$ 9.25M$ 7.90M$ 6.47M
Net Debt$ 12.52M$ 9.99M$ 9.23M$ 7.68M$ 6.38M
Total Liabilities$ 22.93M$ 19.08M$ 15.81M$ 13.04M$ 10.14M
Stockholders' Equity$ -22.46M$ -18.80M$ -15.61M$ -12.63M$ -9.83M
Cash Flow
Free Cash Flow$ -2.73M$ -2.68M$ -2.35M$ -3.14M$ -3.38M
Operating Cash Flow$ -2.73M$ -2.68M$ -2.35M$ -3.14M$ -3.38M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 3.12M$ 2.74M$ 2.15M$ 3.27M$ 3.23M
Currency in USD

Cell Source Earnings and Revenue History

Income Statement >

Cell Source Debt to Assets

Balance Sheet >

Cell Source Cash Flow

Cash Flow >

Cell Source Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >